Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2021-09-15
|
| gptkbp:ATCCode |
L01EB10
|
| gptkbp:brand |
gptkb:Exkivity
|
| gptkbp:CASNumber |
gptkb:2389149-74-6
|
| gptkbp:chemicalFormula |
C32H39N9O4
|
| gptkbp:developer |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:genericName |
mobocertinib
|
| https://www.w3.org/2000/01/rdf-schema#label |
Exkivity
|
| gptkbp:indication |
gptkb:non-small_cell_lung_cancer
NSCLC with EGFR exon 20 insertion mutations |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
gptkb:EGFR_tyrosine_kinase_inhibitor
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea fatigue rash decreased appetite stomatitis paronychia |
| gptkbp:target |
gptkb:EGFR
|
| gptkbp:bfsParent |
gptkb:Takeda_(in_Japan)
gptkb:Mobocertinib gptkb:Takeda_Pharmaceutical |
| gptkbp:bfsLayer |
7
|